177 related articles for article (PubMed ID: 18696333)
1. Oridonin induces human melanoma A375-S2 cell death partially through inhibiting insulin-like growth factor 1 receptor signaling.
Wang HJ; Li D; Yang FY; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2008; 10(7-8):787-98. PubMed ID: 18696333
[TBL] [Abstract][Full Text] [Related]
2. Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome.
Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2004 Jun; 6(2):127-38. PubMed ID: 15008459
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
[TBL] [Abstract][Full Text] [Related]
4. Interruption of mitochondrial complex IV activity and cytochrome c expression activated O₂·⁻-mediated cell survival in silibinin-treated human melanoma A375-S2 cells via IGF-1R-PI3K-Akt and IGF-1R-PLC γ-PKC pathways.
Jiang YY; Huang H; Wang HJ; Wu D; Yang R; Tashiro S; Onodera S; Ikejima T
Eur J Pharmacol; 2011 Oct; 668(1-2):78-87. PubMed ID: 21703257
[TBL] [Abstract][Full Text] [Related]
5. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
[TBL] [Abstract][Full Text] [Related]
7. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Guo ZM; Tashiro S; Onodera S; Ikejima T
FEBS J; 2009 Mar; 276(5):1291-306. PubMed ID: 19187231
[TBL] [Abstract][Full Text] [Related]
8. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line.
Hu HZ; Yang YB; Xu XD; Shen HW; Shu YM; Ren Z; Li XM; Shen HM; Zeng HT
Acta Pharmacol Sin; 2007 Nov; 28(11):1819-26. PubMed ID: 17959034
[TBL] [Abstract][Full Text] [Related]
9. Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway.
Li D; Wu LJ; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2008; 10(1-2):77-87. PubMed ID: 18058384
[TBL] [Abstract][Full Text] [Related]
10. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
11. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide excision repair is not required for the antiapoptotic function of insulin-like growth factor 1.
Lee-Kwon W; Park D; Bernier M
Exp Cell Res; 1998 Jun; 241(2):458-66. PubMed ID: 9637787
[TBL] [Abstract][Full Text] [Related]
13. Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine.
Yoon CH; Kim MJ; Park MT; Byun JY; Choi YH; Yoo HS; Lee YM; Hyun JW; Lee SJ
Mol Cancer Res; 2009 Mar; 7(3):361-70. PubMed ID: 19276187
[TBL] [Abstract][Full Text] [Related]
14. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.
Sadagurski M; Yakar S; Weingarten G; Holzenberger M; Rhodes CJ; Breitkreutz D; Leroith D; Wertheimer E
Mol Cell Biol; 2006 Apr; 26(7):2675-87. PubMed ID: 16537911
[TBL] [Abstract][Full Text] [Related]
17. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
Sarfstein R; Werner H
J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
[TBL] [Abstract][Full Text] [Related]
18. Activation of pro-apoptotic p38-MAPK pathway in the prostate cancer cell line M12 expressing a truncated IGF-IR.
Wu J; Haugk K; Plymate SR
Horm Metab Res; 2003; 35(11-12):751-7. PubMed ID: 14710354
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
Cohen BD; Baker DA; Soderstrom C; Tkalcevic G; Rossi AM; Miller PE; Tengowski MW; Wang F; Gualberto A; Beebe JS; Moyer JD
Clin Cancer Res; 2005 Mar; 11(5):2063-73. PubMed ID: 15756033
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]